TrialTrials2018

SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.

Simon Crabb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.